Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
8
COUR Quote, Financials, Valuation and Earnings
Last price:
$6.49
Seasonality move
:
-17.05%
Day range:
$6.41 - $6.69
52-week range:
$5.76 - $13.56
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.45x
P/B ratio:
1.72x
Volume:
3.8M
Avg. volume:
3.8M
1-year change:
-21.96%
Market cap:
$1.1B
Revenue:
$694.7M
EPS (TTM):
-$0.28
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $293.5M | $415.3M | $523.8M | $635.8M | $694.7M | |
| Revenue Growth (YoY) | 59.16% | 41.49% | 26.12% | 21.39% | 9.27% | |
| Cost of Revenues | $138.8M | $165.8M | $192.3M | $306M | $323.3M | |
| Gross Profit | $154.7M | $249.5M | $331.5M | $329.8M | $371.4M | |
| Gross Profit Margin | 52.7% | 60.07% | 63.29% | 51.87% | 53.47% | |
| R&D Expenses | $76.8M | $135.4M | $165.1M | $160.1M | $132M | |
| Selling, General & Admin | $144.5M | $257.1M | $333.6M | $321.1M | $343.6M | |
| Other Inc / (Exp) | $120K | -$346K | -$12.6M | $5.8M | -$11M | |
| Operating Expenses | $221.2M | $392.5M | $498.7M | $481.2M | $465.2M | |
| Operating Income | -$66.6M | -$143.1M | -$167.2M | -$151.4M | -$93.8M | |
| Net Interest Expenses | $12K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$65.3M | -$143.1M | -$170.6M | -$111.2M | -$78.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.5M | $2.1M | $4.7M | $5.4M | $1M | |
| Net Income to Company | -$66.8M | -$145.2M | -$175.4M | -$116.6M | -$79.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$66.8M | -$145.2M | -$175.4M | -$116.6M | -$79.5M | |
| Basic EPS (Cont. Ops) | -$0.50 | -$1.28 | -$1.21 | -$0.77 | -$0.51 | |
| Diluted EPS (Cont. Ops) | -$0.50 | -$1.28 | -$1.21 | -$0.77 | -$0.51 | |
| Weighted Average Basic Share | $132.6M | $113.6M | $145.3M | $151M | $157.4M | |
| Weighted Average Diluted Share | $132.6M | $113.6M | $145.3M | $151M | $157.4M | |
| EBITDA | -$57M | -$128.3M | -$148.7M | -$129.1M | -$68.8M | |
| EBIT | -$66.6M | -$143.1M | -$167.2M | -$151.4M | -$93.8M | |
| Revenue (Reported) | $293.5M | $415.3M | $523.8M | $635.8M | $694.7M | |
| Operating Income (Reported) | -$66.6M | -$143.1M | -$167.2M | -$151.4M | -$93.8M | |
| Operating Income (Adjusted) | -$66.6M | -$143.1M | -$167.2M | -$151.4M | -$93.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $109.9M | $136.4M | $165.5M | $176.1M | $194.2M | |
| Revenue Growth (YoY) | 32.91% | 24.13% | 21.37% | 6.37% | 10.29% | |
| Cost of Revenues | $42.2M | $48.8M | $82.3M | $79.9M | $88.2M | |
| Gross Profit | $67.7M | $87.6M | $83.3M | $96.2M | $106M | |
| Gross Profit Margin | 61.63% | 64.21% | 50.3% | 54.65% | 54.58% | |
| R&D Expenses | $33.9M | $39.4M | $37.6M | $31.6M | $30M | |
| Selling, General & Admin | $65.2M | $84.5M | $85.2M | $86.4M | $91.6M | |
| Other Inc / (Exp) | -$286K | -$976K | -$325K | $219K | -- | |
| Operating Expenses | $99.1M | $123.9M | $122.9M | $118M | $121.6M | |
| Operating Income | -$31.4M | -$36.3M | -$39.6M | -$21.8M | -$15.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$31.7M | -$35M | -$31.1M | -$12.2M | -$7.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $800K | $1M | $1M | $1.5M | $800K | |
| Net Income to Company | -$32.5M | -$36M | -$32.1M | -$13.7M | -$8.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$32.5M | -$36M | -$32.1M | -$13.7M | -$8.6M | |
| Basic EPS (Cont. Ops) | -$0.24 | -$0.25 | -$0.21 | -$0.09 | -$0.05 | |
| Diluted EPS (Cont. Ops) | -$0.24 | -$0.25 | -$0.21 | -$0.09 | -$0.05 | |
| Weighted Average Basic Share | $137.6M | $146M | $150.9M | $157.6M | $164.6M | |
| Weighted Average Diluted Share | $137.6M | $146M | $150.9M | $157.6M | $164.6M | |
| EBITDA | -$27.3M | -$31.5M | -$33.9M | -$15.7M | -$8.3M | |
| EBIT | -$31.4M | -$36.3M | -$39.6M | -$21.8M | -$15.6M | |
| Revenue (Reported) | $109.9M | $136.4M | $165.5M | $176.1M | $194.2M | |
| Operating Income (Reported) | -$31.4M | -$36.3M | -$39.6M | -$21.8M | -$15.6M | |
| Operating Income (Adjusted) | -$31.4M | -$36.3M | -$39.6M | -$21.8M | -$15.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $383.6M | $496.5M | $609.1M | $684.4M | $739.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $162.6M | $181.6M | $280.7M | $319.1M | $337.7M | |
| Gross Profit | $221M | $314.9M | $328.3M | $365.2M | $402.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $120.4M | $160.6M | $165.5M | $137.3M | $120.9M | |
| Selling, General & Admin | $223M | $323.1M | $331.5M | $337.1M | $350.9M | |
| Other Inc / (Exp) | -$140K | -$2.7M | -$4.4M | -$2M | -- | |
| Operating Expenses | $342.7M | $483.7M | $497M | $474.4M | $470.2M | |
| Operating Income | -$121.8M | -$168.8M | -$168.7M | -$109.1M | -$68M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$121.6M | -$167.9M | -$142.3M | -$73.6M | -$45M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.6M | $3.4M | $5.6M | $4.7M | $781K | |
| Net Income to Company | -$124.2M | -$171.4M | -$147.9M | -$78.3M | -$45.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$124.2M | -$171.4M | -$147.9M | -$78.3M | -$45.8M | |
| Basic EPS (Cont. Ops) | -$0.93 | -$1.19 | -$0.99 | -$0.50 | -$0.28 | |
| Diluted EPS (Cont. Ops) | -$0.93 | -$1.19 | -$0.99 | -$0.50 | -$0.28 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$108.3M | -$151.1M | -$147.2M | -$84.6M | -$39.9M | |
| EBIT | -$121.8M | -$168.8M | -$168.7M | -$109.1M | -$68M | |
| Revenue (Reported) | $383.6M | $496.5M | $609.1M | $684.4M | $739.8M | |
| Operating Income (Reported) | -$121.8M | -$168.8M | -$168.7M | -$109.1M | -$68M | |
| Operating Income (Adjusted) | -$121.8M | -$168.8M | -$168.7M | -$109.1M | -$68M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $300.3M | $381.6M | $466.9M | $515.5M | $560.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $122.9M | $138M | $226.4M | $239.6M | $254M | |
| Gross Profit | $177.5M | $243.6M | $240.4M | $275.9M | $306.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $97.1M | $122.3M | $122.7M | $99.9M | $88.8M | |
| Selling, General & Admin | $176.7M | $242.7M | $240.6M | $256.6M | $263.8M | |
| Other Inc / (Exp) | -$251K | -$2.6M | $5.6M | -$2.2M | $1.3M | |
| Operating Expenses | $273M | $365M | $363.3M | $356.5M | $352.6M | |
| Operating Income | -$95.6M | -$121.4M | -$122.8M | -$80.6M | -$46M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$95.6M | -$120.5M | -$92.1M | -$54.6M | -$21.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.9M | $3.2M | $4.1M | $3.3M | $3.1M | |
| Net Income to Company | -$97.5M | -$123.6M | -$96.2M | -$57.9M | -$24.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$97.5M | -$123.6M | -$96.2M | -$57.9M | -$24.2M | |
| Basic EPS (Cont. Ops) | -$0.73 | -$0.86 | -$0.64 | -$0.37 | -$0.15 | |
| Diluted EPS (Cont. Ops) | -$0.73 | -$0.86 | -$0.64 | -$0.37 | -$0.15 | |
| Weighted Average Basic Share | $405.2M | $433.8M | $450.1M | $470.3M | $487.8M | |
| Weighted Average Diluted Share | $405.2M | $433.8M | $450.1M | $470.3M | $487.8M | |
| EBITDA | -$85.1M | -$107.8M | -$106.3M | -$61.8M | -$24.2M | |
| EBIT | -$95.6M | -$121.4M | -$122.8M | -$80.6M | -$46M | |
| Revenue (Reported) | $300.3M | $381.6M | $466.9M | $515.5M | $560.6M | |
| Operating Income (Reported) | -$95.6M | -$121.4M | -$122.8M | -$80.6M | -$46M | |
| Operating Income (Adjusted) | -$95.6M | -$121.4M | -$122.8M | -$80.6M | -$46M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $285.3M | $821.8M | $781M | $722.1M | $727.7M | |
| Short Term Investments | $205.4M | $241.1M | $459.7M | $65.7M | -- | |
| Accounts Receivable, Net | $40.7M | $34.4M | $53.7M | $67.4M | $59.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $15M | $16.5M | $17.6M | $16.6M | $20.2M | |
| Total Current Assets | $341M | $872.7M | $851.8M | $806.1M | $806M | |
| Property Plant And Equipment | $40.3M | $41M | $36.7M | $35.1M | $39.9M | |
| Long-Term Investments | $3.5M | $2.1M | $1.6M | $1.8M | $2.4M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $10.6M | $10.1M | $8.6M | $11.7M | $24.5M | |
| Other Long-Term Assets | $11.7M | $15.4M | $26.4M | $41.2M | $35.2M | |
| Total Assets | $417.6M | $958.9M | $947.6M | $920.5M | $930.3M | |
| Accounts Payable | $51.9M | $72.5M | $89.7M | $124.5M | $123.2M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $7.9M | $8M | $8.7M | $6.6M | $43K | |
| Other Current Liabilities | $4.7M | $7.6M | $7.2M | $7.7M | $12.8M | |
| Total Current Liabilities | $153.6M | $201.1M | $242.4M | $298.3M | $327.5M | |
| Long-Term Debt | $18.3M | $11.9M | $5.8M | $39K | $3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $177.2M | $217.4M | $253M | $304.3M | $332.9M | |
| Common Stock | -- | $1K | $1K | $2K | $2K | |
| Other Common Equity Adj | $20K | -$252K | -$718K | $59K | -- | |
| Common Equity | -$221.8M | $741.5M | $694.6M | $616.2M | $597.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $240.5M | $741.5M | $694.6M | $616.2M | $597.4M | |
| Total Liabilities and Equity | $417.6M | $958.9M | $947.6M | $920.5M | $930.3M | |
| Cash and Short Terms | $285.3M | $821.8M | $781M | $722.1M | $727.7M | |
| Total Debt | $18.3M | $11.9M | $5.8M | $39K | $3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $816.1M | $785.8M | $721.2M | $721M | $797.7M | |
| Short Term Investments | $15M | $361M | $214M | -- | -- | |
| Accounts Receivable, Net | $36M | $54.6M | $62.1M | $47.6M | $58.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $17.5M | $22.3M | $19.5M | $29.6M | -- | |
| Total Current Assets | $869.5M | $862.7M | $802.7M | $796.6M | $877M | |
| Property Plant And Equipment | $42.1M | $38.9M | $35.7M | $39.9M | $41.8M | |
| Long-Term Investments | $2.5M | $2.1M | $3.5M | $658K | $800K | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $10.3M | $9M | $10.7M | $20.5M | -- | |
| Other Long-Term Assets | $13.8M | $20.1M | $38.8M | $32.5M | -- | |
| Total Assets | $954.8M | $956.3M | $914.3M | $914.1M | $995.3M | |
| Accounts Payable | $56.1M | $89.9M | $123.2M | $123.5M | $130.1M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $8M | $8.1M | $7.4M | $755K | -- | |
| Other Current Liabilities | $7.4M | $7.6M | $7.5M | $15.3M | -- | |
| Total Current Liabilities | $181.4M | $235.7M | $295.6M | $314.8M | $349.5M | |
| Long-Term Debt | $13.5M | $7.4M | $1.1M | $3M | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $198.9M | $247.3M | $300.9M | $320.9M | $355.8M | |
| Common Stock | $1K | $1K | $2K | $2K | -- | |
| Other Common Equity Adj | $1K | -$1.5M | -$219K | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $756M | $709M | $613.4M | $593.3M | $639.5M | |
| Total Liabilities and Equity | $954.8M | $956.3M | $914.3M | $914.1M | $995.3M | |
| Cash and Short Terms | $816.1M | $785.8M | $721.2M | $721M | $797.7M | |
| Total Debt | $13.5M | $7.4M | $1.1M | $3M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$66.8M | -$145.2M | -$175.4M | -$116.6M | -$79.5M | |
| Depreciation & Amoritzation | $9.6M | $14.8M | $18.5M | $22.3M | $25.1M | |
| Stock-Based Compensation | $16.8M | $91.2M | $110.8M | $109.6M | $108.1M | |
| Change in Accounts Receivable | -$24.1M | $5.9M | -$20.6M | -$14.8M | $7.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$15M | $1.7M | -$38.1M | $29.6M | $95.4M | |
| Capital Expenditures | $11.9M | $14.8M | $15.3M | $21.7M | $36.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$101.4M | -$51.6M | -$234M | $384.8M | $29.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | $58.5M | $36.7M | |
| Other Financing Activities | -$801K | -$13.3M | -$12.2M | -$54.1M | -$33.3M | |
| Cash From Financing | $139M | $550.2M | $12.2M | -$79.2M | -$54.9M | |
| Beginning Cash (CF) | $79.9M | $580.7M | $321.3M | $656.3M | $727.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $22.6M | $500.3M | -$259.8M | $335.2M | $70.3M | |
| Ending Cash (CF) | $102.5M | $1.1B | $61.5M | $991.5M | $798M | |
| Levered Free Cash Flow | -$26.9M | -$13.1M | -$53.3M | $7.9M | $59.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$32.5M | -$36M | -$32.1M | -$13.7M | -$8.6M | |
| Depreciation & Amoritzation | $4.1M | $4.9M | $5.7M | $6.1M | $7.3M | |
| Stock-Based Compensation | $23.4M | $26.4M | $27.9M | $25.3M | $23M | |
| Change in Accounts Receivable | $15.6M | $2.4M | $10.7M | $10.6M | $8.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $10.7M | $4.8M | $19.8M | $27.8M | $33.9M | |
| Capital Expenditures | $3.8M | $3.8M | $6.2M | $11.1M | $7.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $32.2M | $39.1M | $137.1M | -$11.1M | -$7.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | $5.4M | -- | -- | |
| Other Financing Activities | -$4M | -$1.9M | -$13.8M | -$7M | -- | |
| Cash From Financing | $8.5M | $913K | -$12.4M | -$5.6M | -$3.9M | |
| Beginning Cash (CF) | $801.1M | $424.8M | $507.2M | $721M | $797.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $51.4M | $44.8M | $144.4M | $11.1M | $22.7M | |
| Ending Cash (CF) | $852.5M | $469.6M | $651.5M | $732.2M | $820.4M | |
| Levered Free Cash Flow | $6.9M | $965K | $13.5M | $16.7M | $26.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$124.2M | -$171.4M | -$147.9M | -$78.3M | -$45.8M | |
| Depreciation & Amoritzation | $13.2M | $17.8M | $21.5M | $24.5M | $28.2M | |
| Stock-Based Compensation | $73.4M | $99.2M | $116.8M | $110.8M | $95.9M | |
| Change in Accounts Receivable | -$15M | -$19.7M | -$8.6M | $13.6M | -$11.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$16.6M | -$31.8M | $12.6M | $87.7M | $122.1M | |
| Capital Expenditures | $11.7M | $15.9M | $18.4M | $30.1M | $34.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $168.5M | -$365.3M | $142.1M | $185.9M | -$34.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | $58.5M | $36.7M | -- | |
| Other Financing Activities | -- | -$10.3M | -$43.8M | -$43.7M | -- | |
| Cash From Financing | $544.4M | $20.3M | -$72.6M | -$60.8M | -$11M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $696.3M | -$376.8M | $82.1M | $212.7M | $76.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$31.2M | -$47.7M | -$5.7M | $57.6M | $87.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$97.5M | -$123.6M | -$96.2M | -$57.9M | -$24.2M | |
| Depreciation & Amoritzation | $10.5M | $13.5M | $16.5M | $18.7M | $21.8M | |
| Stock-Based Compensation | $67.9M | $75.9M | $81.9M | $83.1M | $71M | |
| Change in Accounts Receivable | $4.5M | -$21.1M | -$9M | $19.3M | $1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $941K | -$32.6M | $18.1M | $76.1M | $102.9M | |
| Capital Expenditures | $11.7M | $12.8M | $15.9M | $24.3M | $22.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $178.3M | -$135.4M | $240.7M | $41.7M | -$22.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | $58.5M | $36.7M | -- | |
| Other Financing Activities | -$10.1M | -$7.1M | -$38.7M | -$28.3M | -$13.1M | |
| Cash From Financing | $542M | $12.1M | -$72.7M | -$54.3M | -$10.4M | |
| Beginning Cash (CF) | $1.7B | $1.2B | $1.1B | $2.2B | $2.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $721.2M | -$155.9M | $186M | $63.6M | $70.1M | |
| Ending Cash (CF) | $2.4B | $1B | $1.3B | $2.2B | $2.4B | |
| Levered Free Cash Flow | -$10.8M | -$45.4M | $2.2M | $51.9M | $80.5M | |
Related Companies
Get COUR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
COUR
Sector
P/E ratio
--
17.44x
PEG ratio
--
0.11x
P/B ratio
1.72x
1.33x
Price / LTM sales
1.45x
0.59x
Growth Metrics
COUR
Sector
Revenue growth
10.29%
3.38%
Earnings growth
39.86%
--
Revenue (5-year growth)
30.38%
3.16%
Earnings forecast
$0.06
$0.26
Profitability
COUR
Sector
Profitability FY 2024
$371.4M
$293.9M
Return on invested capital
-7.44%
3.41%
Return on assets
-4.8%
2.25%
Return on equity
-7.47%
5.88%
Earnings Date
Last Earnings Date
Oct
23
Next Earnings Date
Jan
29
Estimated Next Earnings Date
Jan
22
Balance Sheet
COUR
Sector
Total cash
$797.7M
$128.4M
Short term investments
--
$40.6M
Total assets
$930.3M
$1.1B
Long term debt
--
$33.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Buy
53
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
80
BNR alert for Jan 15
Burning Rock Biotech Ltd. [BNR] is up 18.69% over the past day.
Sell
37
TCOM alert for Jan 15
Trip.com Group Ltd. [TCOM] is down 2.31% over the past day.
Sell
39
DAVE alert for Jan 15
Dave, Inc. [DAVE] is up 3.48% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
